Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-05

Clinical Trial Update: iSTEP-N 101b: Pharmacokinetics and Safety Study of Low- and High-Dose Naltrexone Implants vs Monthly Vivitrol in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics and safety study evaluating low- and high-dose naltrexone implants versus monthly Vivitrol in healthy volunteers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naltrexone implant (low-dose/high-dose) (naltrexone)
  • Vivitrol (naltrexone extended-release injectable)

Snippet

Sponsor: Akyso Therapeutics, LLC | Conditions: Opioid Use Disorder | Phase 1 | Status: NOT_YET_RECRUITING